StockData
SHCNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

Sotera Health Co

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$17.64−0.25 (-1.40%)

Close on Oct 19, 2026

Market cap
$5.08B
P/E (TTM)
30.9
Dividend yield
–

Sotera Health Co revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Sterigenics$755.78M$697.85M$667.13M$626.65M$571.83M$498.77M$471.71M65.0%+8.3%
Nelson Labs$220.22M$229.23M$221.70M$223.40M$219.14M$204.64M$190.45M18.9%-3.9%
Nordion$187.62M$173.36M$160.46M$153.64M$140.51M$114.75M$116.17M16.1%+8.2%
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019YoY
Sterigenics$412.89M$378.17M$362.21M$339.14M–––+9.2%
Nordion$107.58M$101.22M$96.68M$89.48M–––+6.3%
Nelson Labs$73.33M$69.18M$69.14M$77.63M–––+6.0%

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Service$995.76M$941.82M$905.60M$864.83M$805.50M$713.52M$673.04M85.6%+5.7%
Product$167.86M$158.62M$143.69M$138.86M$125.98M$104.64M$105.29M14.4%+5.8%

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
United States$629.54M$616.68M$590.97M$579.02M$527.91M$490.50M$473.96M54.1%+2.1%
Europe$232.18M$196.01M$187.54M$166.03M$161.81M$135.72M$122.61M20.0%+18.5%
Canada$221.95M$208.89M$192.05M$188.74M$177.88M$135.94M$130.47M19.1%+6.3%
Other$79.95M$78.86M$78.73M$69.90M$63.89M$56.00M$51.29M6.9%+1.4%

From the segment and revenue-disaggregation notes of Sotera Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.